Zelira Therapeutics (AU:ZLD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zelira Therapeutics has announced its Annual General Meeting (AGM) to be held on 14 November 2024, with the agenda including the adoption of financial reports, auditor appointments, and resolutions on director re-elections and share issuance capacities. The meeting will be accessible both online and at the company’s Perth location. Shareholder participation is critical as decisions made will impact shareholding and the company’s governance.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.